Ensemble Orthopedics Gains FDA Clearance For PyroCarbon CMC Interpositional Implant

Ensemble CMC

Ensemble Orthopedics received FDA 510(k) clearance to market the Ensemble CMC Implant to treat early-stage osteoarthritis of the carpometacarpal (CMC) joint in a minimally invasive procedure.

Ensemble CMC is based on On-X® PyroCarbon, a proprietary form of pyrolytic carbon produced by On-X Life Technologies. The high strength, low modulus...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0